Rabu, 10 Juni 2026 - 17:00 WIB

Find and Follow Us

Global Markets

IHSG 5,902.38 +0.00%

S&P 500 7,386.65 -0.26%

NASDAQ 25,678.82 -0.97%

Dow Jones 50,872.11 +0.17%

FTSE 100 10,175.78 +0.00%

CAC 40 8,176.14 +0.00%

Nikkei 225 64,179.27 +0.00%

Hang Seng 24,407.96 +0.00%

Shanghai 3,993.23 +0.00%

KOSPI 7,730.82 +0.00%

STI 4,958.85 +0.00%

ASX 200 8,653.30 +0.00%

Sensex 74,030.83 +0.00%

Gold 4,190.10 -1.64%

Silver 63.99 -1.70%

Oil (WTI) 88.09 -0.12%

Brent 91.33 -0.13%

Copper 6.24 -0.93%

Gas Alam 3.14 +0.06%

Bitcoin 61,264.42 -0.62%

Ethereum 1,621.95 -0.96%

USD/IDR 17,950.00 -1.32%

EUR/USD 1.16 +0.28%

Advertisement

Fasilitas Produksi Daewoong Pharmaceutical Indonesia di Jababeka, Cikarang

Fexuprazan Resmi Meluncur: Perkuat Lanskap Terapi GERD Nasional

Redaksi • 17 April 2026

Latest Updates

- Advertisement -

Fasilitas Produksi Daewoong Pharmaceutical Indonesia di Jababeka, Cikarang

23:13 WIB • 17 April 2026

Fexuprazan Resmi Meluncur: Perkuat Lanskap Terapi GERD Nasional

Mengusung mekanisme P-CAB (Potassium-Competitive Acid Blocker), Fexuprazan bekerja dengan cara yang lebih langsung menghambat…